Case report:
            <scp>SARS‐CoV</scp>
            ‐2‐induced urticaria or just a concomitance?

Fida, Monika; Mala, Ritjana; Pupo, Laerta; Dibra, Arvin; Nasto, Kristiana

doi:10.1111/dth.14250

Cited by 4 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…COVID-19 infection may appear as a trigger or predisposing factor for the initiating of urticaria. Cofactors such as stress may also contribute to the urticaria being expressed (4).…”

Section: Introductionmentioning

confidence: 99%

COVID-19 in a Depressed Patient with Generalized Urticaria

Bidaki¹,

Zarnegar²,

Saghafi³

2022

APTJ

View full text Add to dashboard Cite

Health concerns, changes in lifestyle, job losses, economic hardships, and the death of family members during the Covid-19 pandemic have led to depressive disorders. Here, a 39-year-old man referred to a psychiatric clinic with the complication of depressed mood, which was exacerbated by stress, anxiety, restlessness, and insomnia. In addition, he was referred to a cardiologist and dermatologist because of uncontrolled tachycardia and urticaria. After detailed examination, the final diagnosis was COVID-19, along with anxiety disorder and dermatological diseases. Since the Coronavirus disease (COVID-19) can cause stress and psychological problems, it can disrupt the patient's healing process if ignored. On the other hand, there seems to be a strong association between psychiatric illnesses with COVID-19 and urticaria that can be investigated.

show abstract

“…COVID-19 infection may appear as a trigger or predisposing factor for the initiating of urticaria. Cofactors such as stress may also contribute to the urticaria being expressed (4).…”

Section: Introductionmentioning

confidence: 99%

COVID-19 in a Depressed Patient with Generalized Urticaria

Bidaki¹,

Zarnegar²,

Saghafi³

2022

APTJ

View full text Add to dashboard Cite

show abstract

Azithromycin/ceftriaxone/hydroxychloroquine

2020

Reactions Weekly

View full text Add to dashboard Cite

A 54-year-old man developed acute urticaria during off treatment with ceftriaxone and hydroxychloroquine for Coronavirus disease 2019 (COVID-19). Additionally, the treatment with azithromycin also contributed in the development of acute urticaria [routes not stated; not all dosages stated]. The man was admitted with dry cough, difficulty breathing and fever. Following examinations, he was diagnosed with COVID-19. He was treated with hydroxychloroquine (400mg twice daily on the first day, followed by 200mg twice daily), ceftriaxone 1000mg twice daily and oxygen therapy. After 14 days of treatment, his oro-pharyngeal and nasal swab tests found to be negative. Subsequently, he was discharged from the hospital and prescribed azithromycin for the next 5 days. Two days after completing the azithromycin course and 3 weeks after completion of ceftriaxone and hydroxychloroquine therapy, he developed pruritic sensation, an acute episode of erythematous elements and intensive itching. The next day, he developed hives over his legs, back and trunk. He had no history of hives, allergies, autoimmune disease or thyroid. He had a positive dermographism. Clinical examination showed itching and whealing. Based on these clinical presentation a diagnosis of acute urticaria was made. The man was treated with unspecified corticosteroids and antihistamine successfully with good control of itching and wheals.

show abstract